Answers are grounded in this paper and cite their sources.
There is increasing evidence that lifestyle interventions and pharmacological treatment can help prevent or delay cognitive decline and dementia, including Alzheimer’s disease. However, early identification of the disease remains a major clinical challenge. Reliable detection at preclinical stage requires repeated longitudinal cognitive assessments; yet traditional paper-and-pencil tests offer a limited number of alternate versions, leading to practice effects that can mask true cognitive changes. In contrast, digital cognitive assessments provide essentially unlimited test variability and can be self-administered, reducing complexity and the cost of longitudinal monitoring. The Boston Cognitive Assessment (BoCA) is a validated, self-administered, 10-minute digital measure of global cognition across eight core domains, that employs randomly selected, non-repeating tasks to avoid practice effects. This study aimed to evaluate participant adherence to the weekly self-assessment protocol and to quantify BoCA’s practice effects and Minimal Detectable Change. Volunteers (n = 100; mean age 61.0 ± 15.7 years) were instructed to complete BoCA weekly without reminders or monetary compensation. Most inter-test intervals clustered around 7 days, indicating strong adherence to the weekly schedule. BoCA demonstrated no statistically significant practice effects (p = 0.557) and excellent long-term reliability (ICC = 0.81). These findings support BoCA as a practical tool for longitudinal monitoring of global cognition.
No takes yet. Share an insight, caveat, or question.
Vyshedskiy et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: